on December 27, 2007
Published online before print December 27, 2007, doi: 10.1161/ATVBAHA.107.151175
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 3, 2007
Accepted on December 1, 2007
p38 MAPK Inhibition Reduces Aortic Ultrasmall Superparamagnetic Iron Oxide Uptake in a Mouse Model of Atherosclerosis. MRI Assessment
Joanne B. Morris ;
From Laboratory Animal Science (J.B.M.), Cardiovascular and Urogenital Center of Excellence in Drug Discovery (A.R.O., R.E.B., K.A., R.N.W., B.M.J.), and Safety Assessment (R.C.M., R.B.), GlaxoSmithKline, King of Prussia, Pa.
* To whom correspondence should be addressed. E-mail: beat.m.jucker{at}gsk.com.
Objective—Ultrasmall superparamagnetic iron oxide (USPIO) contrast agents have been used for noninvasive MRI assessment of atherosclerotic plaque inflammation. The purpose of this study was to noninvasively evaluate USPIO uptake in aorta of apoE-/- mice and to determine the effects of Angiotensin II (Ang II) infusion and chronic antiinflammatory treatment with a p38 MAPK inhibitor on this uptake.
Methods and Results—ApoE-/- mice were administered saline or Ang II (1.44 mg/kg/d) for 21 days. In vivo MRI assessment of USPIO uptake in the aortic arch was observed in all animals. However, although the Ang II group had significantly higher absolute iron content (
103%, P<0.001) in the aortic arch compared with the saline group, the p38 MAPK inhibitor (SB-239063, 150 mg/kg/d) treatment group did not (6%, NS). The in vivo MRI signal intensity was significantly correlated to the absolute iron content in the aortic arch. Histological evaluation of the aortic root lesion area showed colocalization of USPIO with macrophages and a reduction in USPIO but not macrophage content with SB-239063 treatment.
Conclusion—The present study demonstrates that noninvasive assessment of USPIO uptake, as a marker for inflammation in murine atherosclerotic plaque, is feasible and that p38 MAPK inhibition attenuates the uptake of USPIO in aorta of Ang II–infused apoE-/- mice.
Key words: atherosclerosis • inflammation • magnetic resonance imaging • USPIO • apoE-/- • p38 MAPK
This article has been cited by other articles:
 |
|
 |
|
  R. N. Willette, M. E. Eybye, A. R. Olzinski, D. J. Behm, N. Aiyar, K. Maniscalco, R. G. Bentley, R. W. Coatney, S. Zhao, T. D. Westfall, et al. Differential Effects of p38 Mitogen-Activated Protein Kinase and Cyclooxygenase 2 Inhibitors in a Model of Cardiovascular Disease J. Pharmacol. Exp. Ther., September 1, 2009; 330(3): 964 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H.F. Rudd, F. Hyafil, and Z. A. Fayad Inflammation Imaging in Atherosclerosis Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1009 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Osborn and F. A. Jaffer The year in molecular imaging. J. Am. Coll. Cardiol. Img., January 1, 2009; 2(1): 97 - 113. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bulat, G. Waeber, and C. Widmann LDLs stimulate p38 MAPKs and wound healing through SR-BI independently of Ras and PI3 kinase J. Lipid Res., January 1, 2009; 50(1): 81 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Klug, L. Bauer, and W.R. Bauer Patterns of USPIO Deposition in Murine Atherosclerosis Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): e157 - e157. [Full Text] [PDF]
|
|
|
|
|
|
J. B. Morris, A. R. Olzinski, and B. M. Jucker Patterns of USPIO Deposition in Murine Atherosclerosis Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): e158 - e159. [Full Text] [PDF]
|
|